HEALTH

Pace Wellness launches pediatric electrolyte strips

BY Michael Johnsen
CHANDLER, Ariz. – Pace Wellness earlier this week launched Solves Strips Pediatric Electrolyte Oral Thin-Film, a disruptive innovation for medicine delivery. 
 
"Working in pediatric medicine for the past 15 years, including emergency medicine at the Alberta Children's Hospital, I have witnessed the potentially serious impact that dehydration and electrolyte loss can have on children. It can be difficult to quickly provide a child with the necessary electrolytes without resorting to salty electrolyte solutions that are not tolerated," stated Vincent Grant, Pace Wellness healthcare advisor. "This is why the new Solves Strips Pediatric Electrolyte product is an excellent addition to any doctor's or medical provider's resource arsenal. It allows the easy replacement of some of the lost electrolytes, while allowing the more liberal use of fluids that the child is more familiar with, or even enjoys." 
 
The pediatric electrolyte strips are formulated with a controlled dosage of essential electrolytes. They are specifically formatted for children 2 years and older to quickly replenish electrolytes and aid fluid retention. The OTF delivery system vastly improves upon conventional drug delivery systems for young children where swallowing liquids or chewing a solid dosage is daunting or difficult. The easy to take and administer strips are a safe and effective product that replaces lost electrolytes associated with symptoms of flu, diarrhea, vomiting or extreme climates.
 
Solves Strips Pediatric Electrolyte strips are grape flavored and come in a cassette of 10 strips. Each strip contains a total of 35 mg of sodium and potassium.
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Perrigo names new leader of company’s Branded Consumer Healthcare division

BY Michael Johnsen
DUBLIN – Perrigo on Thursday announced that Sharon Kochan, Perrigo EVP and general manager, international, will have expanded responsibilities that will now include providing leadership and strategic direction to the company's Branded Consumer Healthcare segment following the resignation of Marc Coucke, who previously served as EVP and general manager of the BCH segment.
 
"Sharon's background and ability to drive individuals and organizations to peak performance made my decision to appoint him to lead the BCH team a clear one," stated John Hendrickson, Perrigo CEO. "Perrigo is well-positioned for a great future, and the BCH team and business are important parts of that future. Perrigo is committed to the long-term prospects for the segment, and I am confident that we have the right team in place to lead and support this growing business during this transition," he said. "Aligned with the actions that we are taking to drive improved performance in the BCH segment, we have accepted the resignation of Marc Coucke. The board and management team wish Marc well in his future endeavors."
 
Kochan was named Perrigo's EVP and general manager, international in August 2012. He served as EVP and general manager of Rx pharmaceuticals from March 2007 to August 2012 and as SVP business development and strategy from March 2005 to March 2007. 
 
Prior to joining Perrigo, Kochan was VP business development of Agis Industries from July 2001 until the acquisition of Agis by Perrigo in March 2005. 
 
Kochan holds a B.Sc. degree in Industrial Engineering, cum laude, from Tel-Aviv University, and a M.Sc. degree in Management Science – Operations Research from Columbia University in the City of New York.
 
"Given BCH's expansive distribution platform, strong portfolio of OTC brands and the entrepreneurial spirit of its employees, I am confident that the business is well-positioned for success and I am very pleased to be a part of that promising future," Kochan said. 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
HEALTH

Moberg Pharma focuses on speed of results in new Kerasal campaign

BY Michael Johnsen

 
 
STOCKHOLM – Moberg Pharma in March launched a new national ad campaign for its Kerasal Fungal Nail Renewal brand, with a “strong media plan,” according to company executives, and featuring a new TV commercial. 
 
Though still in the early stages, initial results have been very positive, Moberg executives told DSN in late April. The brand’s new positioning and advertising is based on extensive consumer research fielded by the company in 2015, and is focused sharply on improving nail appearance. In addition, Moberg has also unveiled new packaging graphics for it, and sister brand Kerasal Intensive Foot Repair, a leading exfoliating moisturizing product for severely dry feet. 
 
The Kerasal nail relaunch also includes an impactful in-store program, professional marketing, heavy couponing and digital marketing.
 
 
 
 
keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?